Document Detail


Hospital-Onset Seizures: An Inpatient Study.
MedLine Citation:
PMID:  23319087     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES To describe demographic and clinical characteristics of patients with hospital-onset seizure (HOS) and to explore current practices in their management. DESIGN Retrospective medical record review. SETTING Academic, tertiary care, private (New York University Langone Medical Center) and municipal (Bellevue Hospital Center) medical centers. PATIENTS Patients aged at least 18 years with HOS from January 1 through December 31, 2007. Patients admitted for evaluation of seizures or epilepsy were excluded. MAIN OUTCOME MEASURES Hospital-onset seizure patterns, medication use, and outcomes. RESULTS We identified 218 patients with HOS; 139 (64%) had no history of seizure. Hospital-onset seizures were recurrent in 134 patients (61%) during the inpatient stay and were more likely to recur in those with new-onset seizure vs those with a history of seizure (43% vs 32%, P = .09). The most commonly described HOS in patients with a history of seizure and patients with new-onset seizure was a generalized tonic-clonic seizure (72 [33%]). Metabolic derangements were the most common identifiable cause of HOS (43 of 218 [20%]) and new-onset seizures (35 of 139 [25%]) and were more likely to recur. Phenytoin was the most common antiepileptic drug prescribed de novo (61%). Death during hospitalization or discharge to hospice was more common in patients with new-onset seizures compared with those with a history of seizure (19% vs 5%, P = .004). Among surviving patients discharged with a prescription of antiepileptic drugs, phenytoin and levetiracetam were prescribed most often. CONCLUSIONS Hospital-onset seizures commonly occur as new-onset seizures, are typically recurrent, and are associated with a high mortality. Older antiepileptic drugs are often prescribed at seizure presentation and at discharge.
Authors:
Madeline C Fields; Daniel L Labovitz; Jacqueline A French
Related Documents :
24800407 - Program cuts 30-day readmit rate to 10.6%.
23312937 - Effect of hospital-level variation in the use of carotid artery stenting versus carotid...
23394357 - Treating pediatric hydrocephalus in australia: a 3-year hospital-based cost analysis an...
24462027 - Effect of delay in hospital presentation on clinical and imaging findings in acute pulm...
10177737 - Medicare program; payment for preadmission services--hcfa. final rule.
24800407 - Program cuts 30-day readmit rate to 10.6%.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-14
Journal Detail:
Title:  JAMA neurology     Volume:  -     ISSN:  2168-6157     ISO Abbreviation:  JAMA Neurol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101589536     Medline TA:  JAMA Neurol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-5     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of liver biopsy in the era of direct-acting antivirals.
Next Document:  Efficacy and tolerability of moxifloxacin in 2338 patients with acute exacerbation of chronic bronch...